3D BioSol™ Technology

3D BioSol™ - The Bonds Bio Innovation

Our 3D BioSol™ Platform of mini-organs and services helps you gain physiological relevance immediately

In our facilities, an experienced team of 3D professionals engineers and manufactures scaffold-free adipose tissue and heart models (and vascular organoids soon). In order to provide users with the most accurate models for exploring metabolic disorders and cellular cardiotoxicity, our models are created using robust 3D BioSol™ technologies and processes.

Our proprietary and easy-to-use formats integrate easily into your drug discovery and development workflows, so you can focus on what matters.

Relevance

3D BioSol™ Process provides in-vivo-like morphology and functionality.

The ability to capture the long-term effects of drugs that have superior longevity.

Quality Assurance

Ensure consistency from lot to lot with pre-qualified donor materials.

Ensure that your models are functionally valid and certified using 3D applications to reduce the likelihood of failure.

Efficiency

Provide mini-organs on-demand while maintaining experimental flexibility.

Receive assay solutions ready-to-use with 3D mini-organs, optimized media, and certified protocols.

3D BioSol™ Process

Designed to Improve Science

Bringing innovation to every mini-organ we produce

Using the 3D BioSol™ Process, we are able to create 3D mini-organs that have unsurpassed physiological relevance and uniform quality. By combining proprietary techniques, media formulations, and innovative tissue engineering approaches, our scientists create models that are suitable for 3D optimization.

With our solutions, we can match our models to your needs, regardless of the type of 3D culture plate or system.

By leveraging our combined expertise, you can move quickly through material sourcing, development, production, and quality control steps while extending your research resources. Consequently, you can make better and faster decisions about your compounds' safety and efficacy sooner.

3D BioSol™ Applications

Enhance your drug efficacy and safety testing with 3D BioSol™

Bonds Biosystems collaborates with representatives from the pharmaceutical, life science (academy and other companies), and regulatory communities to develop standards and protocols for using advanced 3D models and technology platforms for drug discovery, development, and disease modeling.

We have validated and optimized 3D-cell-based assays and endpoints for several drug discovery and development applications, spanning applications from the early phases to post-market in vitro studies.

By investing in 3D BioSol™ discovery and safety platforms, you will have access to our 3D BioSol™ mini-organs, specially formulated media kits, rigorously tested disease inducer protocols, optimized technical methods and procedures, and expert support services.